Online first
Short communication
Published online: 2025-01-15
Angiogenic markers as prognostic tools in patients with COVID-19: CRACoV-HHS study
Pubmed: 39821615
Abstract
Not available
References
- Covid- L. COVID-19 Epidemiological Update Key highlights 2025.
- Gallo G, Calvez V, Savoia C. Hypertension and COVID-19: Current evidence and perspectives. High Blood Press Cardiovasc Prev. 2022; 29(2): 115–123.
- Pająk A, Jankowski P, Zdrojewski T. The burden of cardiovascular disease risk factors: A current problem. Kardiol Pol. 2022; 80(1): 5–15.
- Stepan H, Hund M, Andraczek T. Combining biomarkers to predict pregnancy complications and redefine preeclampsia: The angiogenic-placental syndrome. Hypertension. 2020; 75(4): 918–926.
- Wojciechowska E, Cienszkowska K, Ludwiczak M, et al. Uncontrolled blood pressure according to ambulatory blood pressure monitoring values in pregnant women is poorly predictable. Kardiol Pol. 2023; 81(7-8): 763–765.
- Nägele MP, Haubner B, Tanner FC, et al. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atherosclerosis. 2020; 314: 58–62.
- National Institutes of Health. Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19). Nih [Internet]. 2021; 2019: 1–243. . https://www.covid19treatmentguidelines.nih.gov/.%0Ahttps://www.covid19treatmentguidelines.nih.gov/ (accessed: November 5, 2024).
- Sydor W, Wizner B, Strach M, et al. CRACoV-HHS: An interdisciplinary project for multi-specialist hospital and non-hospital care for patients with SARS-CoV-2 infection as well hospital staff assessment for infection exposure. Folia Med Cracov. 2021; 61(4): 5–44.
- Zhang JJ, Dong X, Liu GH, et al. Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clin Rev Allergy Immunol. 2023; 64(1): 90–107.
- Terlecki M, Wojciechowska W, Klocek M, et al. Association between cardiovascular disease, cardiovascular drug therapy, and in-hospital outcomes in patients with COVID-19: data from a large single-center registry in Poland. Kardiol Pol. 2021; 79(7-8): 773–780.
- Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020; 383(2): 120–128.
- Pine AB, Meizlish ML, Goshua G, et al. Circulating markers of angiogenesis and endotheliopathy in COVID-19. medRxiv. 2020.
- Mohebbi A, Haybar H, Nakhaei Moghaddam F, et al. Biomarkers of endothelial dysfunction are associated with poor outcome in COVID-19 patients: A systematic review and meta-analysis. Rev Med Virol. 2023; 33(4): e2442.
- Smadja DM, Guerin CL, Chocron R, et al. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis. 2020; 23(4): 611–620.
- Madureira G, Soares R. The misunderstood link between SARS-CoV-2 and angiogenesis. A narrative review. Pulmonology. 2023; 29(4): 323–331.
